Home Blood Pressure Monitoring Registration Study in the Elderly(HOME Study)

NCT04212468 | Recruiting DMC

• 1 other identifier: 2018300H(R1)
• Study Type: observational
• Target: 6,000
• Locations: 1 country
• Sites: 2

Brief Summary

China is entering an aging society. As the number of elderly population continues to increase, the elderly are facing many social problems that deserve the attention of all sectors of society. Hypertension is one of the common diseases in the elderly population. Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. Home blood pressure monitoring is simple, not only can find hypertension, but also can guide the treatment of patients with hypertension. The purpose of the study is to investigate the association between home blood pressure and adverse outcomes in community elderly population.

Conditions

Blood Pressure

Keywords

Blood Pressure; Elderly

Outcome Measures

Primary Outcomes (2)

• All-Cause Mortality

  All-cause mortality was confirmed through a combination of hospital medical records, telephone contacts with patients or family members, and death registration at the Center for Disease Control and Prevention.

  From date of inclusion until the date of death from any cause, assessed up to 1 year

• Cardiovascular Mortality

  Cardiovascular mortality was defined as death attributable to an ischemic cardiovascular cause (including fatal cardiovascular events and stroke).

  From date of inclusion until the date of death from any cause, assessed up to 1 year

Secondary Outcomes (5)

• Secondary outcomes of cardiovascular diseases

  Through study completion, an average of 1 years

• Secondary outcomes of cerebrovascular diseases

  Through study completion, an average of 1 years

• Secondary outcomes of kidney

  Through study completion, an average of 1 years

• Secondary outcomes of hypertension

  Through study completion, an average of 1 years

• Secondary outcomes of diabetes

  Through study completion, an average of 1 years

Other Outcomes (1)

• Number of participants with reported hospitalization due to other diseases

  From date of inclusion until the date of first event, assessed up to 1 year

Interventions

no intervention OTHER

no intervention

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Study population includes subjects who living in community, of any race or ethnicity, 65 or older years of age.

You may qualify if:

• ≥65 years old
• Signed informed consent
• Life expectancy is greater than 1 year

You may not qualify if:

• \<65 years old
• Unsigned informed consent

Sponsors & Collaborators

• Guangdong Provincial People's Hospital: lead

Study Sites (2)

Feng Yingqing

Guangzhou, Guangdong, 510080, China

NOT YET RECRUITING

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, 510080, China

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

This study will collect 20 mL whole blood samples from subjects at one or more study visits. The whole blood will be processed to plasma and stored for testing.

Study Officials

• Feng Ying-qing, PhD

  Guangdong Provincial People's Hospital

  STUDY CHAIR

Central Study Contacts

Feng Ying-qing, PhD

CONTACT

+862083827812; 651792209@qq.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 30 Years
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 24, 2019
• First Posted: December 27, 2019
• Study Start: January 1, 2020
• Primary Completion: December 31, 2024
• Study Completion (Estimated): December 31, 2050
• Last Updated: January 13, 2020

Record last verified: 2019-12

Data Sharing

• IPD Sharing: Will not share

Locations

CN (2)